Health economic evaluation in rare disease genomics

an international perspective

Zornitza Stark, Deborah Schofield, Clara Gaff

Research output: Non-traditional research outputWeb publication/site

Abstract

The recent health economic evaluation of whole-exome sequencing in clinical genetics published by the PHG Foundation provides a valuable UK perspective to the emerging body of health economics studies in rare disease genomics.

The diagnostic and clinical utility of genomic sequencing for rare disease diagnostics is well recognised. However there is a need to develop sustainable funding models and provide evidence of cost effectiveness to support the widespread implementation of genomic sequencing in routine healthcare, as advocated in the recent report by the UK’s Chief Medical Officer, Generation Genome.
Original languageEnglish
PublisherUniversity of Cambridge
Media of outputOnline
Publication statusPublished - 14 Sep 2017
Externally publishedYes

Keywords

  • diagnostics and testing
  • rare diseases

Fingerprint Dive into the research topics of 'Health economic evaluation in rare disease genomics: an international perspective'. Together they form a unique fingerprint.

  • Cite this

    Stark, Z. (Author), Schofield, D. (Author), & Gaff, C. (Author). (2017). Health economic evaluation in rare disease genomics: an international perspective. Web publication/site, University of Cambridge. Retrieved from http://www.phgfoundation.org/blog/health-economic-evaluation-rare-disease-genomics